Texarkana Texas Chosen For COVID-19 Treatment Center

TEXARKANA, TX—Judge Bobby Howell and Texarkana, Texas Mayor Bob Bruggeman received notification this week from the Texas Department of Emergency Management that Texarkana has been chosen as a site for a regional monoclonal antibody infusion treatment center in the battle against COVID-19.

It is anticipated that the site will be operational within the week, and is located at 401 Industrial Boulevard, Nash, TX.

While the treatment is an outpatient process, patients must have a physician’s order to seek the antibody infusion, called Regeneron. Patients are a candidate for the treatment if they meet one or more of the following criteria:

  • 65 years of age or older
  • Obesity or being overweight
  • Pregnancy
  • Chronic Kidney Disease
  • Diabetes
  • Immunosuppressive Disease
  • Receiving Immunosuppressive Treatment
  • Cardiovascular disease or hypertension
  • Chronic lung diseases
  • Sickle Cell Disease
  • Neurodevelopmental disorders or other conditions that confer medical complexity
  • Having a medical related technological dependence

If you have received a positive COVID-19 result and think you may be a candidate for this treatment, please consult your physician.

The treatment is not authorized for patients who are hospitalized due to COVID-19, who require oxygen therapy due to COVID-19, or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.